InsidersTradesSigma
Explore the complete record of transactions filed by Amoroso Michael, Chairman & CEO. Director active across 1 companies, notably Abeona Therapeutics INC.. Cumulatively, 2 reports have been recorded. Total volume traded: €85k. The latest transaction was disclosed on 30 September 2021 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Michael Amoroso is the Chief Executive Officer of Abeona Therapeutics Inc. He is responsible for the strategic direction of the company, focusing on the development of innovative therapies. His experience in the biopharmaceutical sector is a valuable asset for Abeona's growth.